Author:
Hunger Stephen P.,Conter Valentino,Raetz Elizabeth A.,Valsecchi Maria Grazia,Henze Guenter
Publisher
Springer Berlin Heidelberg
Reference272 articles.
1. Abshire TC, Buchanan GR et al (1992) Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Leukemia 6(5):357–362
2. ACUTE LEUKEMIA GROUP B, Freireich EJ et al (1963) The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukemia: a model for evaluation of other potentially useful therapy. Blood 21(6):699–716
3. Administration, U. S. F. a. D. (2007) Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics. Silver Spring, MD
4. Agency EM (2008) Methodological considerations for using progression free survival (PFS) as primary endpoint in confirmatory trials for registration. www.emea.europa.eu/pdfs/human/ewp/2799408en.pdf
5. Angiolillo AL, Yu AL et al (2009) A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children’s Oncology Group report. Pediatr Blood Cancer 53(6):978–983
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献